Prempro news | Breaking Prempro news | Prempro

Panel cites 'information gap' on relieving menopause

..."In the post-Women's Health Initiative era, there has been a lot of confusion about how to manage the symptoms of menopause," said Mangione, a professor of medicine at the University of California, Los Angeles.

Mangione's panel called for a new study to fill the knowledge gaps about treating menopausal symptoms, which it identified as hot flashes, night sweats, vaginal dryness and a possibility of sleep disturbances.

The study should compare the long-term risks and benefits of three to five years of treatment with low-dose hormone therapy, the panel said.

Participants should represent a variety of ethnic groups and body sizes to determine the role of such factors in menopausal symptoms and treatment.

"These are very expensive studies to undertake," Mangione acknowledged.

"At the same time, this is a condition that affects a lot of women in the United States." Cynthia Pearson, executive director of the National Women's Health Network, praised the panel's push for more research.

"Women can make very good decisions about their own health if they have very good information on which to base those decisions," Pearson said.

The full text of the panel's draft statement is available online at consensus.nih.gov.

The final version of the statement will be available at the same Web address in about four weeks.-start data for usatc appM...

NIH Panel supports use of hormone therapy for treatment of ...

... "Medicine and science continue to evolve, and Wyeth is committed to offering menopausal women and their health care providers innovative, well- studied products to meet individual treatment goals and risks," said Dr.

Stiles.

http://www.wyeth.com/ Monthly Sponsors Life Insurance Quote News-Medical.Net...

Medical News From Around The World Back to Top News-Medical.Net Provides this Medical News and Information Service in accordance with these terms and conditions ...

NIH State-of-the-Science Panel Supports Use of Hormone Therapy for ...

... "Medicine and science continue to evolve, and Wyeth is committed to offering menopausal women and their health care providers innovative, well- studied products to meet individual treatment goals and risks," said Dr.

Stiles.

About the PREMARIN Family of Products Wyeth Pharmaceuticals is the leader in women's health, with a long history of product innovation.

Its low dose hormone therapies are part of a family of well-studied products, which includes multiple strengths of PREMARIN and Currently taken by about 4 million women in the United States alone, these products are prescribed more often than any other brand of postmenopausal HT.

What is the most important information you should know about PREMARIN (estrogens) or * Estrogens increase the chances of getting cancer of the uterus.

Report any unusual vaginal bleeding right away while you are taking these products.

Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Your health care provider should check any unusual vaginal bleeding to find out the cause.

* Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia.

Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cance...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Health and Fitness